These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 35239525)

  • 1. Total Neoadjuvant Therapy Significantly Increases Complete Clinical Response.
    Rettig RL; Beard BW; Ryoo JJ; Kulkarni S; Gulati M; Tam M; Attaluri V
    Dis Colon Rectum; 2023 Mar; 66(3):374-382. PubMed ID: 35239525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved Survival After Adjuvant Therapy in Locally Advanced Rectal Cancer Patients With Pathologic Complete Response.
    Lai SH; Vogel JD; Vemuru S; Messersmith W; Lieu C; McCarter MD; Birnbaum E; Chapman BC
    Dis Colon Rectum; 2023 Jul; 66(7):983-993. PubMed ID: 36602514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-Course Radiotherapy Followed by Consolidation Chemotherapy Is Safe and Effective in Locally Advanced Rectal Cancer: Comparative Short-term Results of Multicenter Propensity Score Case-Matched Study.
    Benlice C; Koc MA; Gulcu B; Bilgin IA; Akyol C; Baca B; Ozturk E; Guney Y; Utkan G; Er O; Agaoglu F; Yildirim I; Avci N; Elhan AH; Kuzu MA
    Dis Colon Rectum; 2023 May; 66(5):681-690. PubMed ID: 36856669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ Preservation in Patients with Rectal Cancer Treated with Total Neoadjuvant Therapy.
    Jimenez-Rodriguez RM; Quezada-Diaz F; Hameed I; Kalabin A; Patil S; Smith JJ; Garcia-Aguilar J
    Dis Colon Rectum; 2021 Dec; 64(12):1463-1470. PubMed ID: 34508014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limits of Clinical Restaging in Detecting Responders After Neoadjuvant Therapies for Rectal Cancer.
    Deidda S; Spolverato G; Capelli G; Bao RQ; Bettoni L; Crimì F; Zorcolo L; Pucciarelli S; Restivo A
    Dis Colon Rectum; 2023 Jul; 66(7):957-964. PubMed ID: 36538694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant Modified FOLFOXIRI With Selective Radiotherapy in Locally Advanced Rectal Cancer: Long-term Outcomes of Phase II Study and Propensity-Score-Matched Comparison With Chemoradiotherapy.
    Zhang J; Li J; Huang M; Xie X; Cai Y; Hu H; Ling J; Wu Z; Deng Y
    Dis Colon Rectum; 2023 Jul; 66(7):934-945. PubMed ID: 35834598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Sarcopenia Predict Local Response Rates After Chemoradiotherapy for Locally Advanced Rectal Cancer?
    Bedrikovetski S; Traeger L; Vather R; Sammour T; Moore JW
    Dis Colon Rectum; 2023 Jul; 66(7):965-972. PubMed ID: 36538702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rectal Cancer: Clinical and Molecular Predictors of a Complete Response to Total Neoadjuvant Therapy.
    Chapman BC; Lai SH; Friedrich T; Lieu CH; Moskalenko M; Olsen JR; Herter W; Birnbaum EH; McCarter MD; Vogel JD
    Dis Colon Rectum; 2023 Apr; 66(4):521-530. PubMed ID: 34984995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total Neoadjuvant Therapy With Short-Course Radiation: US Experience of a Neoadjuvant Rectal Cancer Therapy.
    Chapman WC; Kim H; Bauer P; Makhdoom BA; Trikalinos NA; Pedersen KS; Glasgow SC; Mutch MG; Silviera ML; Roy A; Parikh PJ; Hunt SR
    Dis Colon Rectum; 2022 Feb; 65(2):198-206. PubMed ID: 34990423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed TME Surgery in a Watch-and-Wait Strategy After Neoadjuvant Chemoradiotherapy for Rectal Cancer: An Analysis of Hospital Costs and Surgical and Oncological Outcomes.
    Meyer VM; Meuzelaar RR; Schoenaker IJH; de Groot JB; Reerink O; de Vos Tot Nederveen Cappel WH; Beets GL; van Westreenen HL
    Dis Colon Rectum; 2023 May; 66(5):671-680. PubMed ID: 34856587
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Longitudinal MRI-Based Artificial Intelligence System to Predict Pathological Complete Response After Neoadjuvant Therapy in Rectal Cancer: A Multicenter Validation Study.
    Ke J; Jin C; Tang J; Cao H; He S; Ding P; Jiang X; Zhao H; Cao W; Meng X; Gao F; Lan P; Li R; Wu X
    Dis Colon Rectum; 2023 Dec; 66(12):e1195-e1206. PubMed ID: 37682775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Impact of Chronic Kidney Disease in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemoradiation.
    Dudani S; Marginean H; Gotfrit J; Tang PA; Monzon JG; Dennis K; Kennecke HF; Powell ED; Babak S; Cheung WY; Vickers MM
    Dis Colon Rectum; 2021 Dec; 64(12):1471-1478. PubMed ID: 34657078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circumferential Resection Margin as Predictor of Nonclinical Complete Response in Nonoperative Management of Rectal Cancer.
    Chin RI; Schiff JP; Shetty AS; Pedersen KS; Aranha O; Huang Y; Hunt SR; Glasgow SC; Tan BR; Wise PE; Silviera ML; Smith RK; Suresh R; Byrnes K; Samson PP; Badiyan SN; Henke LE; Mutch MG; Kim H
    Dis Colon Rectum; 2023 Jul; 66(7):973-982. PubMed ID: 36876988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Lymphatic Invasion, Venous Invasion, Perineural Invasion, and Tumor Budding in Rectal Cancer Treated With Neoadjuvant Chemoradiotherapy Followed by Total Mesorectal Excision.
    Kim S; Huh JW; Lee WY; Yun SH; Kim HC; Cho YB; Park YA; Shin JK
    Dis Colon Rectum; 2023 Jul; 66(7):905-913. PubMed ID: 35195558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study.
    Han K; Tang JH; Liao LE; Jiang W; Sui QQ; Xiao BY; Li WR; Hong ZG; Li Y; Kong LH; Li DD; Zhang XS; Pan ZZ; Steele SR; Ding PR
    Dis Colon Rectum; 2023 Oct; 66(10):e996-e1005. PubMed ID: 35485833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.
    Williams H; Thompson HM; Lin ST; Verheij FS; Omer DM; Qin LX; Garcia-Aguilar J;
    Dis Colon Rectum; 2024 Mar; 67(3):369-376. PubMed ID: 38039292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Risk of Distant Metastases in Patients With Clinical Complete Response Managed by Watch and Wait After Neoadjuvant Therapy for Rectal Cancer: The Influence of Local Regrowth in the International Watch and Wait Database.
    Fernandez LM; São Julião GP; Renehan AG; Beets GL; Papoila AL; Vailati BB; Bahadoer RR; Kranenbarg EM; Roodvoets AGH; Figueiredo NL; Van De Velde CJH; Habr-Gama A; Perez RO;
    Dis Colon Rectum; 2023 Jan; 66(1):41-49. PubMed ID: 36515514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Survival With ypT0N+ Following Neoadjuvant Therapy in Rectal Cancer.
    Elshami M; Goldstone RN; Blaszkowsky LS; Cusack JC; Hong TS; Wo JY; Qadan M
    Dis Colon Rectum; 2022 Oct; 65(10):1224-1231. PubMed ID: 35714358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Total Neoadjuvant Therapy on Postoperative Outcomes After Proctectomy for Rectal Cancer.
    Xu Z; Valente MA; Sklow B; Liska D; Gorgun E; Kessler H; Rosen DR; Steele SR
    Dis Colon Rectum; 2023 Jul; 66(7):1022-1028. PubMed ID: 36538720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rectal Cancer Survival for Residual Carcinoma In Situ Versus Pathologic Complete Response After Neoadjuvant Therapy.
    Kohrman NM; Wlodarczyk JR; Ding L; McAndrew NP; Algaze SD; Cologne KG; Lee SW; Koller SE
    Dis Colon Rectum; 2024 Jul; 67(7):920-928. PubMed ID: 38498775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.